Hansoh Pharma stock fell 1.97 percent to HKD 33.92

Published on 10/08/2026 at 02:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hansoh Pharma stock posted RMB 4.258 billion in first-half profit on August 26, 2026, up 35.82 percent year over year. The shares were last at HKD 33.92 on October 7.

Hansoh Pharma, KYG549581067, Illustration mit AI erstellt.

Hansoh Pharma (ISIN KYG549581067) was last at HKD 33.92 on the Hong Kong Stock Exchange on October 7, 2026 at 4:08 p.m. HKT, down 1.97 percent from HKD 34.60. The latest earnings picture remains the central company figure, with first-half profit rising 35.82 percent year over year.

Profit rises faster than revenue

According to GMT Eight on August 26, 2026, Hansoh reported revenue of RMB 8.304 billion for the six months ended June 30, 2026, up 11.71 percent from the prior-year period.

Attributable profit reached RMB 4.258 billion, compared with the 35.82 percent year-over-year increase, while basic earnings per share stood at RMB 0.70. The company attributed the profit and earnings-per-share gains to higher innovative-drug revenue and increased other income, according to GMT Eight.

Innovative drugs drive the mix

Hansoh's first-half operating profile is increasingly concentrated in innovative medicines. The company website describes oncology, metabolism, immunology, central nervous system and anti-infective treatments as its main therapy areas, with more than 70 innovative-drug clinical trials covering more than 40 candidates.

The earnings report also proposed an interim dividend of HKD 0.285 per share. Simply Wall St lists October 29, 2026 as the payment date for the interim dividend and identifies 24 analysts contributing estimates to its coverage.

Consensus target stays above the price

The same Simply Wall St page lists a consensus price target of HKD 46.03. That target lies 35.7 percent above the HKD 33.92 market price, making the valuation gap a more visible issue than the modest one-session decline.

Hansoh's October 7 market capitalization was HKD 205.7 billion, with 4,236,135 shares traded. Its 52-week range was HKD 28.06 to HKD 44.22, placing the latest price 23.3 percent below the yearly high and 20.9 percent above the yearly low.

Hansoh Pharma stock stays below its yearly high

Hansoh Pharma stock was last at HKD 33.92 on October 7, 2026 at 4:08 p.m. HKT on the Hong Kong Stock Exchange, while first-half revenue and profit were RMB 8.304 billion and RMB 4.258 billion.